COVID-19 |
Coronavirus disease 2019 |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
WHO |
World health organization |
+ssRNA |
Positive single-strand RNA virus |
MERS |
Middle east respiratory syndrome |
ACE2 |
Angiotensin-converting enzyme 2 |
RdRp |
RNA-dependent RNA polymerase |
FDA |
Food and Drug Administration |
EUA |
Emergency use authorization |
GMP |
Good manufacturing practice |
CEPI |
Coalition for epidemic Preparedness Innovations |
EU |
ELISA units |
NIAID |
National institute of allergy and infectious diseases |
GMT |
Geometric mean titers |